Qyuns Therapeutics Co., Ltd. (HKG:2509)

Qyuns Therapeutics Revenue

Qyuns Therapeutics had revenue of 424.06M CNY in the half year ending June 30, 2026, with 844.05% growth. This brings the company's total for the last twelve months to 1.02B, up 219.81% year-over-year. In the year 2025, Qyuns Therapeutics had annual revenue of 806.96M with 408.18% growth. That makes Qyuns Therapeutics the 19,574th largest company in the world by revenue and 1,141st in Hong Kong.

• Revenue (ttm): 1.02B CNY
• Revenue Growth: +219.81%
• P/S Ratio: 3.16
• Revenue / Employee: 2.90M CNY
• Employees: 353
• Market Cap: 3.70B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Switzerland 504.60M 62.5%
• The United States 197.80M 24.5%
• The People's Republic of China (The "PRC") 104.56M 13.0%

Fiscal year ended Dec 31, 2025 See the full Qyuns Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	806.96M	648.17M	408.18%
Dec 31, 2024	158.79M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	9.66M	-11.69M	-54.74%
Dec 31, 2021	21.35M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 19, 2026

Data Sources Report a data error